Form 4 for NTRA Natera, Inc.
Accepted 2024-12-11 00:00:00 ET · period of report 2024-12-09 · accession 0001415889-24-029036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-11 | 2024-12-09 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $166.59 | -4,858 | 114.9K | -4% | -$809.3K |
| DM | 2024-12-11 | 2024-12-09 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | $9.43 | +9,075 | 116.4K | +8% | +$85.6K |
| DM | 2024-12-11 | 2024-12-09 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | M - OptEx | $0.00 | -9,075 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-09 | S | D | 4,858 | $166.59 | 114,912 | D | — | — | (F1) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the exercise of options and in compliance with Rule 10b5-1. (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.5937 to $166.5938 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-12-09 | A | A | 3,323 | $12.85 | 119,770 | D | — | — | |
| 3 | Common | Common Stock | 2024-12-09 | A | A | 5,752 | $7.45 | 116,447 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2024-12-09 | M | D | 5,752 | $0.00 | 0 | D | $7.45 · — to 2025-03-25 | 5,752 Common Stock | (F3) The options shares are fully exercisable. |
| 5 | Derivative | Stock Option (right to buy) | 2024-12-09 | M | D | 3,323 | $0.00 | 0 | D | $12.85 · — to 2025-06-17 | 3,323 Common Stock | (F3) The options shares are fully exercisable. |